ArticleAmerican journal of cancer research2022

ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling.

Yanlin Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.